Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

× No keyword cloud information.

29 in total

Review 1. [Systemic treatment of renal cell carcinoma - recent update].

Authors: Birgit Grünberger
Journal: Wien Med Wochenschr Date: 2011-08

2. Endoscopic scene labelling and augmentation using intraoperative pulsatile motion and colour appearance cues with preoperative anatomical priors.

Authors: Masoud S Nosrati; Alborz Amir-Khalili; Jean-Marc Peyrat; Julien Abinahed; Osama Al-Alao; Abdulla Al-Ansari; Rafeef Abugharbieh; Ghassan Hamarneh
Journal: Int J Comput Assist Radiol Surg Date: 2016-02-12 Impact factor: 2.924

Review 3. Differentiating mTOR inhibitors in renal cell carcinoma.

Authors: Sumanta K Pal; David I Quinn
Journal: Cancer Treat Rev Date: 2013-02-21 Impact factor: 12.111

Review 4. Treatment selection in metastatic renal cell carcinoma: expert consensus.

Authors: Bernard Escudier; Cezary Szczylik; Camillo Porta; Martin Gore
Journal: Nat Rev Clin Oncol Date: 2012-04-10 Impact factor: 66.675

5. Addition of DHA Synergistically Enhances the Efficacy of Regorafenib for Kidney Cancer Therapy.

Authors: Jeffrey Kim; Arzu Ulu; Debin Wan; Jun Yang; Bruce D Hammock; Robert H Weiss
Journal: Mol Cancer Ther Date: 2016-02-26 Impact factor: 6.261

Review 6. Non-clear cell renal cell carcinoma: does the mammalian target of rapamycin represent a rational therapeutic target?

Authors: Laurence Albiges; Vincent Molinie; Bernard Escudier
Journal: Oncologist Date: 2012-07-17

Review 7. IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.

Authors: Alexandra Kirner; Andrea Mayer-Mokler; Carsten Reinhardt
Journal: Hum Vaccin Immunother Date: 2014 Impact factor: 3.452

8. Experience with sunitinib in the treatment of metastatic renal cell carcinoma.

Authors: Manuela Schmidinger; James Larkin; Alain Ravaud
Journal: Ther Adv Urol Date: 2012-10

9. Allogeneic partially HLA-matched dendritic cells pulsed with autologous tumor cell lysate as a vaccine in metastatic renal cell cancer: a clinical phase I/II study.

Authors: Anne Flörcken; Joachim Kopp; Antje van Lessen; Kamran Movassaghi; Anna Takvorian; Korinna Jöhrens; Markus Möbs; Constanze Schönemann; Birgit Sawitzki; Karl Egerer; Bernd Dörken; Antonio Pezzutto; Jörg Westermann
Journal: Hum Vaccin Immunother Date: 2013-03-04 Impact factor: 3.452

Review 10. Prolonged efficacy of mTOR inhibitors in papillary renal cell carcinoma: progression-free survival lasting for over 3 years, a case report and review of the literature.

Authors: Amaury Daste; Marine Gross-Goupil; Sophie Roca; Jean-Christophe Bernhard; Alain Ravaud
Journal: Target Oncol Date: 2013-01-03 Impact factor: 4.493